Sten Dahlstrand

Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden.

Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden.

Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden.

Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden.

Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden.